Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 185, pseudogene (RNU6-185P)
- Target
- RNU6-185P
- Molecular classification
- Pseudogene, Non-coding RNA (snRNA family, pseudogene subclass)
01
Overview
The *RNA, U6 small nuclear 185, pseudogene* (RNU6-185P) is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family[3]. U6 snRNA itself is an essential, highly conserved component of the spliceosomal machinery responsible for pre-mRNA splicing in eukaryotes, but RNU6-185P does not encode a functional RNA molecule[1][2][3]. Pseudogenes like RNU6-185P are non-coding remnants of once-functional genes; they do not produce active snRNA and have no established biological or clinical role. They can occur in the genome due to retrotransposition events involving U6 snRNA[3], but are not considered molecular targets for therapy, nor are they associated with drug interactions or biomarker use. Therefore, RNU6-185P is not a relevant molecular target for therapeutic intervention.
- Other names
- RNU6-185PU6-185PU6 pseudogene 185
02
Mechanism of action
Not applicable (no known functional activity or drug mechanism)
03
Biological functions
None (pseudogenes do not produce active products)
04
Disease associations
None directly; pseudogenes typically do not have defined pathogenic roles
05
Safety considerations
None known, as this is not a functional or therapeutically actionable molecule
06
Interacting drugs
None
07
Biomarkers
None known for patient selection or monitoring
Beyond the preview
Go deeper on RNA, U6 small nuclear 185, pseudogene (RNU6-185P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 185, pseudogene (RNU6-185P).